[ACRV] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -40.52%
YoY- -53.83%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 CAGR
Revenue 0 0 0 -
PBT -16,486 -12,756 -7,220 51.02%
Tax 181 -1,637 8 374.64%
NP -16,486 -11,119 -7,228 50.93%
Tax Rate - - - -
Total Cost 16,486 11,119 7,228 50.93%
Ratio Analysis
31/03/24 31/03/23 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 CAGR
EPS -0.73 -0.51 -0.56 14.15%
EPS Diluted -0.73 -0.51 -0.56 14.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.